Botox (chronic migraine) denied by insurance? Appeal and win.
Botox denials for chronic migraine are among the most procedural in the whole preventive-migraine category, which is good news for an appeal. Plans almost never argue that Botox does not work for chronic migraine; it is FDA approved for exactly that. They argue that the chart does not yet prove the patient meets the definition of chronic migraine, or that the required older preventives were not tried first. Both are documentation problems, and both are fixable in writing.
Reviewed by the Apellica Appeals Team · Updated June 2026
Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.
Botox (onabotulinumtoxinA) is FDA approved for the prophylaxis of headaches in adults with chronic migraine, defined as 15 or more headache days per month lasting 4 hours a day or longer. It is not FDA approved as a preventive for episodic migraine, which is the single most common reason a denial is clinically correct rather than merely procedural.
Why Botox (chronic migraine) gets denied
- Headache frequency not documented at the threshold: the plan requires the chart to show 15 or more headache days per month, with at least 8 of them migraine days, sustained over at least 3 months. A note saying the patient has frequent or severe migraines does not meet it; a dated headache diary does.
- Step therapy not satisfied: most plans require documented trial and failure, intolerance or contraindication of at least two classes of oral preventive medication, commonly a beta-blocker, a tricyclic such as amitriptyline, and an anticonvulsant such as topiramate or divalproex, each at an adequate dose for an adequate trial.
- Episodic rather than chronic migraine: if the record supports fewer than 15 headache days a month, the request falls outside the FDA indication and the denial is usually correct. The appeal then has to establish the true frequency, not argue the criteria.
- Administration or protocol issues: the plan expects the PREEMPT protocol, 155 units across 31 fixed injection sites, repeated approximately every 12 weeks. Requests with a different unit count, site map or interval are often denied for that reason alone rather than on medical necessity.
- Reauthorization without response data: at renewal the plan asks for evidence of benefit, typically a reduction in headache days per month compared with the documented baseline. Renewals are denied when nobody submitted the after figure.
- Wrong benefit lane: Botox is a clinician-administered injectable, so some plans adjudicate it under the medical benefit and some under the pharmacy benefit. A denial that is really a benefit-routing error gets appealed to the wrong department and times out.
What a strong appeal includes
- A dated headache diary or clinic note covering at least three consecutive months, showing headache days and migraine days per month. This single document resolves more Botox denials than any argument, because the frequency threshold is the criterion most often unproven.
- The correct diagnosis coded as chronic migraine (ICD-10 G43.7 series) rather than a general migraine code, with the chart text supporting the code.
- A prior-therapy table naming each preventive tried, the dose reached, how long it was taken, and precisely why it stopped: no benefit, side effect, or contraindication. Vague phrasing such as failed multiple preventives is what step-therapy denials are made of.
- An explicit statement that the request follows the PREEMPT protocol at 155 units over 31 sites every 12 weeks, which removes the administrative grounds for refusal.
- For a renewal, the before and after headache days per month, and any reduction in acute medication use, which also addresses medication-overuse concerns.
- A request in writing for the plan's own Botox coverage policy and the claim file. Appeals that quote the plan's published criteria back to it, line by line, are answering the actual decision rather than a guess about it.
How we approach the appeal
Treat a Botox denial as an evidence problem first. Read the denial letter and decide which of three things it actually says: the frequency is unproven, the step therapy is unproven, or the patient has episodic migraine. Each has a different answer. For the first two, the appeal is largely an exercise in attaching the diary and the prior-therapy history and mapping them onto the plan's published criteria. For the third, establish the real frequency before arguing anything else, because no amount of advocacy makes episodic migraine an approvable indication. Ask the prescriber for a peer-to-peer review alongside the written appeal: neurologists tend to resolve frequency and protocol questions on the call faster than in writing. If the internal appeal is upheld, external review by an independent organisation is a separate lane, it is free, and the reviewing physician is typically a neurologist rather than a general reviewer.
Botox (chronic migraine) appeal letter template
Copy this Botox (chronic migraine) appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns CGRP migraine therapy adjacent: injectable neurotoxin preventive denials.
[Date] [Your name] · Member ID [ID] · Rx claim # [#] [Insurer or PBM] - Appeals Department Re: Appeal of Botox (chronic migraine) denial I am appealing the denial of Botox (chronic migraine) (onabotulinumtoxinA). I request that the denial be overturned and Botox (chronic migraine) approved. 1. The denial. [Insurer] denied Botox (chronic migraine) stating, verbatim: "[paste the exact denial reason from your letter]." 2. Medical necessity. Botox (chronic migraine) is medically necessary for my condition. Treat a Botox denial as an evidence problem first. Read the denial letter and decide which of three things it actually says: the frequency is unproven, the step therapy is unproven, or the patient has episodic migraine. Each has a different answer. For the first two, the appeal is largely an exercise in attaching the diary and the prior-therapy history and mapping them onto the plan's published criteria. For the third, establish the real frequency before arguing anything else, because no amount of advocacy makes episodic migraine an approvable indication. Ask the prescriber for a peer-to-peer review alongside the written appeal: neurologists tend to resolve frequency and protocol questions on the call faster than in writing. If the internal appeal is upheld, external review by an independent organisation is a separate lane, it is free, and the reviewing physician is typically a neurologist rather than a general reviewer. 3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception. 4. My request. Approve Botox (chronic migraine) within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions. Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes. Sincerely, [Your name]
Want it built and filed for you? Use the free generator, or have Apellica do it.
Commercial and employer plans generally allow at least 180 days from the denial to file an internal appeal, and the decision is due within 30 days before treatment or 60 days after. If the delay itself would cause harm, the request can be marked urgent, which compresses the decision to 72 hours. Medicare Advantage and Part D run on shorter clocks. The date printed on your denial letter controls.
$0 upfront. We assess fit first, then build and file the appeal for you.
- · A headache diary or chart notes covering three or more consecutive months with headache days and migraine days per month
- · The denial letter itself, including the reason and reference numbers
- · A prior-therapy list: drug, dose, duration and reason each preventive was stopped
- · A letter of medical necessity mapping the case to the plan's published Botox criteria
- · The plan's own coverage policy for onabotulinumtoxinA, requested in writing if not supplied
- · For renewals, documented headache days since starting treatment
Appealing a Botox (chronic migraine) denial by insurer
The path depends on who manages your benefit. The most common:
Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.
Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.
Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.
Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.
Internal appeals and external review; pharmacy denials often route through OptumRx criteria.
Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.
Frequently asked questions
My plan says Botox is not medically necessary for my migraines. Can I appeal?
Yes, and the odds are better than most people assume, because that phrase usually stands in for a specific unmet criterion rather than a clinical judgement that Botox does not work. Ask in writing for the criteria the decision was based on, then answer the criterion the letter actually cites. Most often it is the 15-headache-days-a-month threshold or the two failed preventives.
I have migraines but fewer than 15 headache days a month. What are my options?
Botox is FDA approved only for chronic migraine at 15 or more headache days a month, so a denial in that situation is usually correct rather than procedural. That does not leave you without options: the CGRP preventives are approved for episodic migraine, and a denial of one of those is appealable on the same documentation logic.
Does it matter whether Botox is billed under my medical or pharmacy benefit?
It matters a great deal for where the appeal goes and which deadline applies. Botox is administered by a clinician, so plans split on this. If the denial came from a pharmacy benefit manager but the drug is administered in the office, confirm which benefit adjudicated it before filing, because an appeal sent to the wrong lane can expire while it is being forwarded.
My Botox worked but the renewal was denied. Why?
Renewal criteria are different from initial criteria. Plans ask for evidence of response, usually a reduction in headache days per month against the documented baseline. If nobody submitted that comparison, the renewal is denied on paper even when the treatment is working. Supplying the before and after figures usually resolves it.
Botox (chronic migraine) denied? We fight it for you.
$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.
Start Your AppealIf Botox (chronic migraine) was denied, read next
- Nurtec denials
- Ajovy denials
- Ubrelvy denials
- Emgality denials
- Aimovig denials
- Vyepti denials
- Qulipta denials
- Your drug is not on the formulary
- Step therapy: getting an override
- Specialty tier and tiering exceptions
- Quantity limits and dose caps
- How medication denials are appealed
This page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.